ABBV - Company ID 0001551152
AbbVie Inc. (ABBV) reported revenue of $61.16B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $61.16B | +8.6% |
| FY 2024 | $56.33B | +3.7% |
| FY 2023 | $54.32B | -6.4% |
| FY 2022 | $58.05B | +3.3% |
| FY 2021 | $56.20B | +22.7% |
| FY 2020 | $45.80B | +37.7% |
| FY 2019 | $33.27B | +1.6% |
| FY 2018 | $32.75B | +16.1% |
| FY 2017 |
AbbVie Inc. (ABBV) reported revenue of $61.16B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, AbbVie Inc.'s revenue grew from $17.44B to $61.16B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $28.22B |
| +10.1% |
| FY 2016 | $25.64B | +12.2% |
| FY 2015 | $22.86B | +14.5% |
| FY 2014 | $19.96B | +6.2% |
| FY 2013 | $18.79B | +2.2% |
| FY 2012 | $18.38B | +5.4% |
| FY 2011 | $17.44B | - |